Editorial on "Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era"

被引：0
作者：
Abu-Ghanem, Yasmin [1 ,2 ]
Ramon, Jacob [1 ,2 ]
机构：
[1] Sheba Med Ctr, Dept Urol, Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
RENAL-CELL CARCINOMA; STRATIFICATION;
D O I：
10.21037/atm.2019.02.25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 11 条
  • [1] Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma
    Bex, Axel
    Albiges, Laurence
    Ljungberg, Borje
    Bensalah, Karim
    Dabestani, Saeed
    Giles, Rachel H.
    Hofmann, Fabian
    Hora, Milan
    Kuczyk, Markus A.
    Lam, Thomas B.
    Marconi, Lorenzo
    Merseburger, Axel S.
    Fernandez-Pello, Sergio
    Tahbaz, Rana
    Abu-Ghanem, Yasmin
    Staehler, Michael
    Volpe, Alessandro
    Powles, Thomas
    [J]. EUROPEAN UROLOGY, 2018, 74 (06) : 805 - 809
  • [2] Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
    Flanigan, RC
    Salmon, SE
    Blumenstein, BA
    Bearman, SI
    Roy, V
    McGrath, PC
    Caton, JR
    Munshi, N
    Crawford, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1655 - 1659
  • [3] Role of cytoreductive nephrectomy in the targeted therapy era: A systematic review and meta-analysis
    Garcia-Perdomo, Herney A.
    Zapata-Copete, James A.
    Castillo-Cobaleda, Diego F.
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2018, 59 (01) : 2 - 9
  • [4] A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: A stratification tool for prospective clinical trials
    Leibovich, BC
    Cheville, JC
    Lohse, CM
    Zincke, H
    Frank, I
    Kwon, ED
    Merchan, JR
    Blute, ML
    [J]. JOURNAL OF UROLOGY, 2005, 174 (05) : 1759 - 1763
  • [5] Temporal trends in venous thromboembolism after radical cystectomy
    Lyon, Timothy D.
    Tollefson, Matthew K.
    Shah, Paras H.
    Bews, Katherine
    Frank, Igor
    Karnes, R. Jeffrey
    Thompson, R. Houston
    Habermann, Elizabeth B.
    Boorjian, Stephen A.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 361.e15 - 361.e21
  • [6] Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
    Mejean, A.
    Ravaud, A.
    Thezenas, S.
    Colas, S.
    Beauval, J. -B.
    Bensalah, K.
    Geoffrois, L.
    Thiery-Vuillemin, A.
    Cormier, L.
    Lang, H.
    Guy, L.
    Gravis, G.
    Rolland, F.
    Linassier, C.
    Lechevallier, E.
    Beisland, C.
    Aitchison, M.
    Oudard, S.
    Patard, J. -J.
    Theodore, C.
    Chevreau, C.
    Laguerre, B.
    Hubert, J.
    Gross-Goupil, M.
    Bernhard, J. -C.
    Albiges, L.
    Timsit, M. -O.
    Lebret, T.
    Escudier, B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05) : 417 - 427
  • [7] Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial
    Mickisch, GHJ
    Garin, A
    van Poppel, H
    de Prijck, L
    Sylvester, R
    [J]. LANCET, 2001, 358 (9286) : 966 - 970
  • [8] Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma
    Motzer, RJ
    Mazumdar, M
    Bacik, J
    Berg, W
    Amsterdam, A
    Ferrara, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2530 - 2540
  • [9] Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
    Motzer, Robert J.
    Bukowski, Ronald M.
    Figlin, Robert A.
    Hutson, Thomas E.
    Michaelson, M. Dror
    Kim, Sindy T.
    Baum, Charles M.
    Kaftan, Michael W.
    [J]. CANCER, 2008, 113 (07) : 1552 - 1558
  • [10] Cytoreductive nephrectomy in the era of targeted therapies: a review
    Pindoria, Nisha
    Raison, Nicholas
    Blecher, Gideon
    Catterwell, Rick
    Dasgupta, Prokar
    [J]. BJU INTERNATIONAL, 2017, 120 (03) : 320 - 328
12